ARCHIVES

NCI To Study Whether It Gets The Most From Advisors.

This article is from The Cancer Letter archive.

Vol. 28 No. 10 | March 8, 2002

Download PDF Visit The Full Archive

Related Articles

Agency Expands Gleevec Label To Include Rare GIST Subset

February 24, 2012

Schmidt’s Doubts Threaten Control Saturation Program

August 22, 1975

Cyramza-Docetaxel Combination Extends OS In Second-Line NSCLC

June 27, 2014

House committee Seeks $239 Million Cut In Clinton’s NIH Budget

March 11, 1994

House approves $210 million for Dept. of Defense cancer research programs.

June 24, 2005

House Subcommittee Recommends $137.7 Million Increase For NCI

June 21, 1996